Aftercare and Management of Central Venous Access Devices

Central Venous Catheters

Volumn , Issue , 2009, Pages 221-237

  Bishop, Liz ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Blood sampling protocol; Catheter rupture; Catheter related bloodstream infections (CRBSIs); Fluoroscopic guided device insertion; Hub contamination; Immediate patient care post catheter insertion; Microbial tracking; Persistent withdrawal occlusion (PWO); Suture removal

Indexed keywords

EID: 84889342206     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470750186.ch14     Document Type: Chapter

References (66)

1. Akl EA, Karmath G, Yosuico V et al. (2007). Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. Cochrane Database of Systematic Reviews (Online) 3:CD006468.
2. Andris D, Krzywda E, Shulte W et al. (1999). Pinch-off syndrome: a rare aetiology for central venous catheter occlusion. Journal of Parenteral and Enteral Nutrition 18:531.
3. Beathard GA (2003). Catheter management protocol for catheter-related bacteremia prophylaxis. Seminars in Dialysis 16:403.
4. Castagnola E, Molinari AC, Fratino G et al. (2003). Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary. British Journal of Haematology 121:233.
5. Centres for Disease Control (CDC) (2002). Guidelines for the prevention of intravascular catheter related infections. Available at http://www.cdc.gov/ncidod/dhqp/glintravascular.html.
6. Cimochowski GE, Worley E, Rutherford WE et al. (1990). Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 54:154.
7. Conn C. (1993). The importance of syringe size when using an implanted vascular access device. Journal of Vascular Access Networks 3:11.
8. Cook RJ, Ashton-Rendell W, Aughenbaugh GL et al. (2005). Septic pulmonary embolism: presenting features and clinical course of 14 patients. Chest 128:162.
9. Cornock M (1996). Making sense of CVCs. Nursing Times 92:30.
10. Couban S, Goodyear M, Burnell M et al. (2005). Randomized placebo-controlled study of lowdose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. Journal of Clinical Oncology 20:4063.
11. Cox CE, Carson SS, Biddle AK (2003). Cost-effectiveness of ultrasound in preventing femoral venous catheter-associated pulmonary embolism. American Journal of Respiratory and Critical Care Medicine 168:1481.
12. Craig D (2003). Clinical techniques. In Conscious Sedation in Gastroenterology: A Handbook for Nurse Practitioners, Skelly M, Palmer D (eds), Whurr Publishers, London, Chapter 4, pp. 50-67.
13. Crnich CJ, Maki DG (2002). The promise of novel technology for the prevention of intravascular device-related blood stream infections. II. Long term devices. Clinical Infectious Diseases 34:1362.
14. Dougherty L, Lister SE (2004). Vascular access devices. In Manual of Clinical Nursing Procedures, Dougherty L, Lister S (eds), 6th edn. Blackwell Science, Oxford.
15. Fletcher SJ, Bodenham AR (1999). Catheter related sepsis: an overview. British Journal of Intensive Care 9:46.
16. Fletcher SJ, Bodenham AR (2000). Safe placement of central venous catheters: where should the tip of the catheter lie? British Journal of Anaesthesia 85:188.
17. Gabriel J, Bravery K, Dougherty L et al. (2005). Vascular access: indications and implications for patient care. Nursing Standard 19:45.
18. Galloway S, Bodenham AR (2004). Long-term central venous access. British Journal of Anaesthesia 92:722.
19. Goodwin M, Carlson S (1993). The peripherally inserted central catheter: a retrospective look at 3 years insertions. Journal of Intravenous Nursing 16:92.
20. Groeger JS, Lucas AB, Thaler HT et al. (1993). Infectious morbidity associated with use of longterm venous access devices in patients with cancer. Annals of Internal Medicine 119:1168.
21. Hadaway LC (1998). Major thrombotic and nonthrombotic complications. Loss of patency. Journal of Intravenous Nursing 21:S143-S160.
22. Haller L, Rush K (1992). CVC infection: a review. Journal of Clinical Nursing 1:61.
23. Hamilton H (2004). Advantages of a nurse-led central venous access vascular service. The Journal of Vascular Access 5:109.
24. Heit JA, O-Fallon WM, Petterson TM et al. (2002). Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Archives of Internal Medicine 162:1245.
25. INS (Intravenous Nursing Society) (2000). Standards for Infusion Therapy, INS and Becton Dickinson, Cambridge, MA.
26. Kelly C (1992). A change in flushing protocol of CVCs. Oncology Nursing Forum 19:599.
27. Krzywda EA (1999). Predisposing factors, prevention, and management of central venous catheter occlusions. Journal of Intravenous Nursing 22:S11-S17.
28. Laxson CJ, Titler MG (1994). Drawing coagulation studies from arterial lines: an integrative literature review. American Journal of Critical Care 3:16.
29. Lee AY (2005). Management of thrombosis in cancer: primary prevention and secondary prophylaxis. British Journal of Haematology 128:291.
30. Linares J, Sitges-Serra A, Garau J (1985). Pathogenesis of catheter sepsis: a prospective study with quantitative and semi-quantitative cultures of catheter hub and segments. Journal of Clinical Microbiology 21:357.
31. Lok-Charmaine E, Appleton D, Bhola C et al. (2007). Trisodium citrate 4% - an alternative to heparin capping of haemodialysis catheters. Nephrology, Dialysis, Transplantation 22:477.
32. MacDonald S, Watt AJ, McNally D et al. (2000). Comparison of technical success and outcome of tunnelled catheters inserted via the jugular and subclavian approaches. Journal of Vascular and Interventional Radiology 11:225.
33. Maki DG, Ringer M (1987). Evaluation of dressing regimes for prevention of infection with peripheral IV catheters. JAMA 258:2396.
34. Mayo D, Pearson D (1995). Chemotherapy extravasation: a consequence of fibrin sheath formation around venous access devices. Oncology Nursing Forum 2:675.
35. McClelland DBL (2007). Handbook of Transfusion Medicine, 4th edn. UK blood transfusion and tissue transplantation services. Electronic version http://www.transfusionguidelines.org/index.asp?Publication=HTM&Section=9&pageid=1100.
36. MHRA (Medicines and Healthcare Products Regulatory Agency) (2005). Medical Device Alert on All Brands of Needle Free Intravascular Connectors, MDA/2005/030. London.
37. Mehall JR, Saltzman DA, Jackson RJ et al. (2002). Fibrin sheath enhances central venous catheter infection. Critical Care Medicine 30:908.
38. Mermel LA (2000). Prevention of intravascular catheter-related infections. Annals of Internal Medicine 132:391.
39. Morris P, Grace S, Glackin V et al. (1995). Audit of skin-tunnelled catheters in neutropenic patients. Bone Marrow Transplantation 15:S2, 168.
40. NICE (National Institute for Clinical Excellence) (2003). Infection control prevention of healthcare associated infection in primary and community care. In Clinical Guidelines 2. DOH, London.
41. Olson K, Rennie RP, Hanson J et al. (2004). Evaluation of a no-dressing intervention for tunnelled central venous catheter exit sites. Journal of Infusion Nursing 27:37.
42. Passannante A, Macik BG (1998). Case report: the heparin flush syndrome: a cause of iatrogenic haemorrhage. American Journal of Medical Science 296:71.
43. Pearson ML (1996). Hospital infection control practices advisory committee. Guideline for prevention of intravascular-device-related infections. Infection Control and Hospital Epidemiology 17:438.
44. Pellowe C, Pratt RJ, Loveday H et al. (2004). The epic project. Updating the evidence base for national evidence-based guidelines for preventing healthcare associated infections in NHS hospitals in England: a report with recommendations. British Journal of Infection Control 5:10.
45. Polderman K, Girbes A (2002). Central venous catheter use. Part 1: mechanical complications. Intensive Care Medicine 28:1.
46. Pratt RJ, Pellow C, Harper P et al. (2001). The epic project: developing evidence-based guidelines for the prevention of healthcare associated infections. Journal of Hospital Infection 47:S1-S82.
47. Pratt RJ, Pellowe C, Wilson JA et al. (2007). Epic2: national evidence -based guidelines for preventing healthcare -associated infections in NHS hospitals in England. Journal of Hospital Infection 65:S1-S64.
48. Raad II, Hohn DC , Gilbreath BJ et al. (1994). Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infection Control and Hospital Epidemiology 15:231.
49. Ray S, Stacey R , ImrieMet al. (1996). A review of 560 catheter insertions. Anaesthesia 51:981.
50. RCN (RCN IV Therapy Forum) (2005). Standards for Infusion Therapy. RCN, London.
51. Reynolds MG, Tebbs SE, Elliott TSJ (1997). Do dressings with increased permeability reduce the incidence of central venous catheter related sepsis. Intensive and Critical Care Nursing 13:26.
52. Rowley S (1997). Aseptic non-touch technique. Nursing Times 7:SV1-SVIII.
53. Schears GJ (2005). The benefits of a catheter securement device on reducing patient complications. Managing Hospital Infection 5:14.
54. Slichter-Sherrill J (2007). Platelet transfusion therapy. Hematology/Oncology Clinics of North America 21:697.
55. Tebbs ST, Trend V, Elliott TSJ (1995). The potential reduction of microbial contamination of central venous catheters. Journal of Infection 30:107.
56. Teichgräber UK, Gebauer B, Benter T et al. (2003). Central venous access catheters: radiological management of complications. Cardiovascular and Interventional Radiology 26:321.
57. Timsit JF, Farkas JC, Boyer JM (1998). Central vein catheter-related thrombosis in intensive care patients: incidence, risk factors and relationship with catheter-related sepsis. Chest 114:207.
58. Todd J (1998). Peripherally inserted central catheters. Professional Nurse 13:297.
59. Trerotola SO, Kuhn-Fulton J, Johnson MG et al. (2000). Tunnelled infusion catheters: increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular venous access. Radiology 217:89.
60. Treston-Aurend J (1997). Impact of dressing materials on central venous catheter infection rates. Journal of Intravenous Nursing 20:201.
61. Vanherweghem JL, Dhaene M, Goldman M et al. (1986). Infections associated with subclavian dialysis catheters: the key role of nurse training. Nephron 4:116.
62. Vygon (2000). Vygon Integrated Product Solutions; Mid to Long Term Vascular Access. Vygon, Cirencester, UK.
63. Waghorn DJ (1994). Intravascular device associated systemic infections: a 2 year analysis of cases in a district general hospital. Journal of Hospital Infection 28:91.
64. Warkentin TE, Levine MN, Hayward CPM et al. (1995). Heparin induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin. New England Journal of Medicine 332:1330.
65. Wickham R, Purl S, Welker D et al. (1992). Long-term CVCs - issues for care. Seminars in Oncology Nursing 8:133.
66. Yamamoto AJ (2002). Sutureless securement device reduces the complications of peripherally inserted central venous catheters. Journal of Vascular and Interventional Radiology 13:77.